Falzone N - Search Results

1

Imaging DNA Damage Repair In Vivo After ¹⁷⁷Lu-DOTATATE Therapy.

O'Neill E, Kersemans V, Allen PD, Terry SYA, Torres JB, Mosley M, Smart S, Lee BQ, Falzone N, Vallis KA, Konijnenberg MW, de Jong M, Nonnekens J, Cornelissen B. O'Neill E, et al. Among authors: falzone n. J Nucl Med. 2020 May;61(5):743-750. doi: 10.2967/jnumed.119.232934. Epub 2019 Nov 22. J Nucl Med. 2020. PMID: 31757844 Free PMC article.

2

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.

Cornelissen B, Darbar S, Kersemans V, Allen D, Falzone N, Barbeau J, Smart S, Vallis KA. Cornelissen B, et al. Among authors: falzone n. Nucl Med Biol. 2012 Nov;39(8):1142-51. doi: 10.1016/j.nucmedbio.2012.06.001. Epub 2012 Jul 18. Nucl Med Biol. 2012. PMID: 22819196

3

PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.

Knight JC, Topping C, Mosley M, Kersemans V, Falzone N, Fernández-Varea JM, Cornelissen B. Knight JC, et al. Among authors: falzone n. Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1707-1717. doi: 10.1007/s00259-015-3092-8. Epub 2015 Jun 2. Eur J Nucl Med Mol Imaging. 2015. PMID: 26031435

4

Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability.

Falzone N, Lee BQ, Able S, Malcolm J, Terry S, Alayed Y, Vallis KA. Falzone N, et al. J Nucl Med. 2018 Jun 29;60(2):250-8. doi: 10.2967/jnumed.117.207308. Online ahead of print. J Nucl Med. 2018. PMID: 29959216 Free PMC article.

5

The Impact of Radiobiologically Informed Dose Prescription on the Clinical Benefit of ⁹⁰Y SIRT in Colorectal Cancer Patients.

Abbott EM, Falzone N, Lee BQ, Kartsonaki C, Winter H, Greenhalgh TA, McGowan DR, Syed N, Denis-Bacelar AM, Boardman P, Sharma RA, Vallis KA. Abbott EM, et al. Among authors: falzone n. J Nucl Med. 2020 Nov;61(11):1658-1664. doi: 10.2967/jnumed.119.233650. Epub 2020 May 1. J Nucl Med. 2020. PMID: 32358093 Free article.

6

Monte Carlo Evaluation of Auger Electron-Emitting Theranostic Radionuclides.

Falzone N, Fernández-Varea JM, Flux G, Vallis KA. Falzone N, et al. J Nucl Med. 2015 Sep;56(9):1441-6. doi: 10.2967/jnumed.114.153502. Epub 2015 Jul 23. J Nucl Med. 2015. PMID: 26205298 Free article.

7

EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.

Song L, Falzone N, Vallis KA. Song L, et al. Among authors: falzone n. Int J Radiat Biol. 2016 Nov;92(11):716-723. doi: 10.3109/09553002.2016.1145360. Epub 2016 Mar 21. Int J Radiat Biol. 2016. PMID: 26999580 Free PMC article.

8

Improved outcome of ¹³¹I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma.

Corroyer-Dulmont A, Falzone N, Kersemans V, Thompson J, Allen DP, Able S, Kartsonaki C, Malcolm J, Kinchesh P, Hill MA, Vojnovic B, Smart SC, Gaze MN, Vallis KA. Corroyer-Dulmont A, et al. Among authors: falzone n. Radiother Oncol. 2017 Sep;124(3):488-495. doi: 10.1016/j.radonc.2017.05.002. Epub 2017 Jun 5. Radiother Oncol. 2017. PMID: 28595752 Free PMC article.

9

Targeted radionuclide therapy in combined-modality regimens.

Gill MR, Falzone N, Du Y, Vallis KA. Gill MR, et al. Among authors: falzone n. Lancet Oncol. 2017 Jul;18(7):e414-e423. doi: 10.1016/S1470-2045(17)30379-0. Lancet Oncol. 2017. PMID: 28677577 Review.

10

Targeted Radionuclide Therapy: New Advances for Improvement of Patient Management and Response.

Malcolm J, Falzone N, Lee BQ, Vallis KA. Malcolm J, et al. Among authors: falzone n. Cancers (Basel). 2019 Feb 25;11(2):268. doi: 10.3390/cancers11020268. Cancers (Basel). 2019. PMID: 30823564 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page